Mesco Pharmaceuticals (Delisted) share news and announcements

BSE: 500274Pharmaceuticals & Biotechnology

Last traded ₹4.54 on 10 Jan 2022

Delisted on 12 Nov 2023.

Mesco Pharmaceuticals routine notices

51 filed, newest first. Page 1 of 2.

Jan 2022
- 3 Jan · Routine
  As per the Securities and Exchange Board of India (Prohibition of Insider Trading)(Amendment) Regulations, 2018 (including Second Amendment in the said Regulations dated July 25, 2019), .... (opens in a new tab)
Nov 2021
- 15 Nov · Routine
  Newspaper publication of Unaudited Financial Results for the Quarter ended 30th September, 2021 (opens in a new tab)
- 9 Nov · Routine
  Newspaper publication for Board Meeting of the Company .... (opens in a new tab)
Sep 2021
- 13 Sep · Routine
  ('SEBI Listing Regulations'), please find enclosed Newspaper Advertisement for the convening .... (opens in a new tab)
- 8 Sep · Routine
  Newspaper Publication of Unaudited Result for the quarter ended 30.06.2021 as per Reg 47 (opens in a new tab)
Jul 2021
- 6 Jul · Routine
  Newspaper publication of the Audited Financial Results .... (opens in a new tab)
Jun 2021
- 30 Jun · Routine
  As per the Securities and Exchange Board of India (Prohibition of Insider Trading)(Amendment) Regulations, 2018 (including Second Amendment in the said Regulations dated July 25, 2019), .... (opens in a new tab)
- 30 Jun · Routine
  In reference with the SEBI circular dated 8th February, 2019 and in compliance with the Regulation 24A of SEBI (Listing and Obligations Requirements) Regulations, 2015, please find enclosed .... (opens in a new tab)
- 24 Jun · Routine
  MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve 1. To consider, approve .... (opens in a new tab)
Mar 2021
- 27 Mar · Routine
  Intimation of Closure of Trading Window under the SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
Feb 2021
- 18 Feb · Routine
  Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2020, received from our Registrar and Transfer Agent i.e. .... (opens in a new tab)
Dec 2020
- 28 Dec · Routine
  Intimation of Closure of Trading Window under the SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
Nov 2020
- 17 Nov · Routine
  Newspaper Advertisement for Unaudited Results for quarter ended 30.09.2020 (opens in a new tab)
- 7 Nov · Routine
  Newspaper Advertisement for Notice of Board Meeting (opens in a new tab)
- 5 Nov · Routine
  MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2020 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
Oct 2020
- 5 Oct · Routine
  Submission of Reconciliation of Share Capital Audit Report as per Regulation 74 (5) of the SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended September 30, 2020 (opens in a new tab)
Sep 2020
- 29 Sep · Routine
  It is hereby intimated that the trading window of the Company would be closed with immediate effect i.e. immediately on close of Trading Hours on BSE on Wednesday, September 30, 2020 and .... (opens in a new tab)
- 11 Sep · Routine
  Newspaper Publication for Notice of Annual General Meeting of the Company (opens in a new tab)
- 9 Sep · Routine
  Newspaper Advertisement for Unaudited Results for quarter ended 30.06.2020 (opens in a new tab)
Aug 2020
- 31 Aug · Routine
  Newspaper Advertisement for Board Meeting of the Company to be held on Thursday, the 3rd of September, 2020 at H-1, Zamrudpur Community Centre, Kailash Colony, New Delhi 110048 published .... (opens in a new tab)
- 29 Aug · Routine
  MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2020 ,inter alia, to consider and approve The standalone unaudited .... (opens in a new tab)
- 29 Aug · Routine
  MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2020 ,inter alia, to consider and approve The standalone unaudited .... (opens in a new tab)
Jul 2020
- 27 Jul · Routine
  Submission of Certificate as per Regulation 74 (5) ofthe SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended June 30, 2020 (opens in a new tab)
- 24 Jul · Routine
  MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2020 ,inter alia, to consider and approve Audited Financial Statements .... (opens in a new tab)
Jun 2020
- 29 Jun · Routine
  Intimation of Closure of Trading Window under the SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
- 18 Jun · Routine
  Submission of Annual Secretarial Compliance Report for the year ended 31st March, 2020 (opens in a new tab)
May 2020
- 4 May · Routine
  We submit herewith certificate received from our Registrar and .... (opens in a new tab)
Mar 2020
- 26 Mar · Routine
  Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's code of conduct for prevention of Insider Trading, the Trading window of the Company .... (opens in a new tab)
Feb 2020
- 5 Feb · Routine
  MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2020 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
Jan 2020
- 21 Jan · Routine
  Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2019 (opens in a new tab)
Dec 2019
- 26 Dec · Routine
  Pursuant to the Provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended) and the Company's Code of Conduct for Prevention of Insider Trading we wish to inform .... (opens in a new tab)
- 19 Dec · Routine
  Pursuant to the request received for Rematerialization of share(s) from the following shareholder, the company has issued share; S.No Folio No Name No of Shares New Certificate No. .... (opens in a new tab)
Nov 2019
- 19 Nov · Routine
  Newspaper publication for un audited financial result for the quarter and half year ended 30th September, 2019 (opens in a new tab)
- 16 Nov · Routine
  Intimation Regarding Issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 (opens in a new tab)
- 6 Nov · Routine
  MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
Oct 2019
- 4 Oct · Routine
  Intimation Regarding Issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 (opens in a new tab)
Sep 2019
- 26 Sep · Routine
  Intimation of Closure of Trading Window under the SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
- 12 Sep · Routine
  ('SEBI Listing Regulations'), please find enclosed .... (opens in a new tab)
Aug 2019
- 5 Aug · Routine
  MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2019 ,inter alia, to consider and approve Pursuant to Regulation .... (opens in a new tab)
Jul 2019
- 12 Jul · Routine
  This is with reference to captioned subject, please find enclosed herewith the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter .... (opens in a new tab)
- 11 Jul · Routine
  We wish to inform that following shareholder has .... (opens in a new tab)
Jun 2019
- 29 Jun · Routine
  Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended and BSE vide circular no. LlST/COMP/01/2019-20 dated 2nd April 2019 .... (opens in a new tab)
- 3 Jun · Routine
  Newspaper publication of Audited Financial Results for the Quarter and Financial Year ended 31st March, 2019 (opens in a new tab)
May 2019
- 27 May · Routine
  Annual Secretarial Compliance Report Sr. No. Particulars Details 1 Period .... (opens in a new tab)
Apr 2019
- 27 Apr · Routine
  Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... (opens in a new tab)
- 3 Apr · Routine
  Pursuant to the Provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended) and the Company's Code of Conduct for Prevention of Insider Trading we wish to inform .... (opens in a new tab)
Feb 2019
- 5 Feb · Routine
  As per the Company's Code of Conduct for Prevention of Insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015, the .... (opens in a new tab)
Aug 2018
- 6 Aug · Routine
  As per the Company's Code of Conduct for Prevention of Insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015, the .... (opens in a new tab)
Feb 2018
- 6 Feb · Routine
  As per the Company's Code of Conduct for Prevention of Insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015, the .... (opens in a new tab)
Nov 2017
- 6 Nov · Routine
  As per the Company's Code of Conduct for Prevention of Insider Trading, framed pursuant to the SEBI (Prohibition of Insider Trading) Regulation 2015, the Trading Window for dealing/trading .... (opens in a new tab)